Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride-containing mesotherapy effectively treats female hair loss, improving density and thickness with minimal side effects.

Higher monocyte counts may predict poor response to adalimumab in hidradenitis suppurativa patients.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Secukinumab and acitretin together may quickly and effectively treat severe generalized pustular psoriasis.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Trastuzumab may cause tufted hair folliculitis as a side effect.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Ocrelizumab helped control lupus in a pregnant patient, leading to the birth of a healthy baby.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Brevilin-A is a safe and effective treatment for mild to moderate alopecia areata in children.

Talquetamab may cause hair loss and skin issues.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

PDLLA scalp injections improved hair regrowth in most patients with non-scarring alopecia.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Non-daily Dutasteride is more cost-effective and has lower cancer incidence than daily treatment.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Semaglutide may help some skin disorders but can also cause skin issues.

DPCP is effective for treating severe alopecia areata, but relapse is common.

A woman with dermatomyositis improved after treatment for neck panniculitis, suggesting similar treatment for related conditions.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

Delonix polymeric nanoparticles with isotretinoin effectively treat acne by targeting hair follicles and reducing skin irritation.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.